Platelet-related indicators for predicting vedolizumab response in patients with Ulcerative Colitis

被引：0
|
作者：
Jiao, J. [1 ]
Liu, W. [1 ]
Wang, B. [1 ]
Cao, H. [1 ]
机构：
[1] Tianjin Med Univ, Gen Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P478
引用
收藏
页码：607 / 607
页数：1
相关论文
共 50 条
  • [1] Impact of disease duration on predicting response to vedolizumab in patients with ulcerative colitis from the Vedolizumab Immunomodulator Enforced Withdrawal Study (VIEWS)
    Choi, R. C-H
    Pudipeddi, A.
    Lin, H.
    Paramsothy, S.
    Ghaly, S.
    Begun, J.
    Kariyawasam, V.
    Yau, Y.
    Fung, C.
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 172 - 173
  • [2] Role of Interleukin-8 in Predicting Long-Term Response to Vedolizumab in Ulcerative Colitis Patients
    Minguez, A.
    Ripoll, P.
    Argumanez, V
    Navarrete, I
    Aguerri, A.
    Garrido, A.
    Aguas, M.
    Iborra, M.
    Cerrillo, E.
    Bastida, G.
    Nos, P.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1761 - i1761
  • [3] Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis
    Chang, Hui-Chin
    Gau, Shuo-Yan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1242 - 1242
  • [4] Predictors of the efficacy of vedolizumab in patients with ulcerative colitis
    Kajikawa, Go
    Sawada, Tsunaki
    Nakamura, Masanao
    Yamamura, Takeshi
    Maeda, Keiko
    Ishikawa, Eri
    Uetsuki, Kota
    Hirose, Takashi
    Iida, Tadashi
    Mizutani, Yasuyuki
    Yamao, Kentaro
    Ishikawa, Takuya
    Furukawa, Kazuhiro
    Kawashima, Hiroki
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2024, 86 (03): : 407 - 421
  • [5] Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis
    Courtney Perry
    Kyle Fischer
    Ahmed Elmoursi
    Cody Kern
    Alden Currier
    Praneeth Kudaravalli
    Olalekan Akanbi
    Nishant Tripathi
    Pradeep Yarra
    Leon Su
    Deborah Flomenhoft
    Arnold Stromberg
    Terrence A. Barrett
    Digestive Diseases and Sciences, 2021, 66 : 2051 - 2058
  • [6] Predictive transcriptional signatures associated to vedolizumab therapy response in patients with ulcerative colitis
    Gomez, M. Camba
    Arosa, L.
    Calvino-Suarez, C.
    Baston-Rey, I.
    Ferreiro-Iglesias, R.
    Porto, M.
    Nieto, L.
    Dominguez-Munoz, J. E.
    Barreiro-De Acosta, M.
    Conde-Aranda, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 818 - 819
  • [7] Transcriptional biomarkers for vedolizumab therapy response in patients with moderate to severe Ulcerative Colitis
    Arosa Garcia, L.
    Camba-Gomez, M.
    Calvino-Suarez, C.
    Baston-Rey, I.
    Ferreiro-Iglesias, R.
    Porto, M.
    Nieto-Garcia, L.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    Conde-Aranda, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I147 - I147
  • [8] Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis
    Perry, Courtney
    Fischer, Kyle
    Elmoursi, Ahmed
    Kern, Cody
    Currier, Alden
    Kudaravalli, Praneeth
    Akanbi, Olalekan
    Tripathi, Nishant
    Yarra, Pradeep
    Su, Leon
    Flomenhoft, Deborah
    Stromberg, Arnold
    Barrett, Terrence A.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (06) : 2051 - 2058
  • [9] Dynamic trajectory of platelet-related indicators and survival of severe COVID-19 patients
    He, Jieyu
    Wei, Yongyue
    Chen, Jiao
    Chen, Feng
    Gao, Wei
    Lu, Xiang
    CRITICAL CARE, 2020, 24 (01)
  • [10] Dynamic trajectory of platelet-related indicators and survival of severe COVID-19 patients
    Jieyu He
    Yongyue Wei
    Jiao Chen
    Feng Chen
    Wei Gao
    Xiang Lu
    Critical Care, 24
12345